ABCSG 34 Summary

A prospective, open, randomized, phase-II-study of a therapeutic cancer vaccine (L-BLP25, Tecemotide) in the pre-operative treatment of women with primary breast cancer.

Start: 01/2012
Coordinating investigator: Gnant, Michael; Vienna
Singer, Christian; Vienna
Sample size: 400
Design:
(Click to enlare)
ABCSG-34-Design

Link for studyteam-members only

Further information about this trial

Access to these informations only with keyword. If required, please ask the responsible project manager.